Tirzepatide Bests Semaglutide for Patients With Type 2 Diabetes

THURSDAY, Oct. 5, 2023 (HealthDay News) -- Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented

Related Keywords

Hamburg ,Germany ,Greece ,Thomas Karagiannis ,Aristotle University Of Thessaloniki ,Lori Solomon ,Healthday News ,European Association ,Diabetes Annual Meeting ,Aristotle University ,Dcc ,Fire ,Tncen ,Ealth And Wellness ,Ealthday ,Physicians Briefing ,Medicine ,Statistics ,Natomy ,